Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey. more
Time Frame | TVGN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.67% | -3.72% | -0.05% |
1-Month Return | -23.31% | -1.85% | 2.75% |
3-Month Return | 123.19% | -11.4% | 7.4% |
6-Month Return | 17.24% | -4.41% | 10.47% |
1-Year Return | -78.66% | 4.13% | 27.57% |
Jun '22 | Jun '23 | Jun '24 | ||||
---|---|---|---|---|---|---|
Total Revenue | - | - | - | [{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] | ||
Cost of Revenue | - | - | - | [{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] | ||
Gross Profit | - | - | - | [{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] | ||
Gross Margin | - | - | - | [{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] | ||
Operating Expenses | 4.62M | 953.08K | 2.27M | [{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":20.64,"profit":true},{"date":"2024-06-30","value":49.24,"profit":true}] | ||
Operating Income | (4.62M) | (13.72M) | (8.84K) | [{"date":"2022-06-30","value":-461846200,"profit":false},{"date":"2023-06-30","value":-1372406400,"profit":false},{"date":"2024-06-30","value":-884303,"profit":false}] | ||
Total Non-Operating Income/Expense | (16.19M) | 4.42M | (314.51K) | [{"date":"2022-06-30","value":-366.13,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-7.11,"profit":false}] | ||
Pre-Tax Income | (15.60M) | 4.41M | (67.33K) | [{"date":"2022-06-30","value":-353.8,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-1.53,"profit":false}] | ||
Income Taxes | (9.78M) | (230.82K) | 255.87K | [{"date":"2022-06-30","value":-3822.82,"profit":false},{"date":"2023-06-30","value":-90.21,"profit":false},{"date":"2024-06-30","value":100,"profit":true}] | ||
Income After Taxes | (5.82M) | 4.64M | (323.19K) | [{"date":"2022-06-30","value":-125.36,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-6.97,"profit":false}] | ||
Income From Continuous Operations | (15.60M) | 4.41M | (67.33K) | [{"date":"2022-06-30","value":-353.8,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-1.53,"profit":false}] | ||
Income From Discontinued Operations | - | - | - | [{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] | ||
Net Income | (15.60M) | 4.41M | (67.33K) | [{"date":"2022-06-30","value":-353.8,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-1.53,"profit":false}] | ||
EPS (Diluted) | 0.00 | 0.12 | (0.37) | [{"date":"2022-06-30","value":3.17,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-310.58,"profit":false}] | ||
These ratios help you determine the liquidity of the company. Higher is better.
TVGN | |
---|---|
Cash Ratio | 0.22 |
Current Ratio | 0.34 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TVGN | |
---|---|
ROA (LTM) | -593.01% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TVGN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 2.44 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -1.44 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TVGN | |
---|---|
Trailing PE | 2.86 |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.00 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | 3.50 |
Tevogen Bio Holdings Inc (TVGN) share price today is $1.02
Yes, Indians can buy shares of Tevogen Bio Holdings Inc (TVGN) on Vested. To buy Tevogen Bio Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TVGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Tevogen Bio Holdings Inc (TVGN) via the Vested app. You can start investing in Tevogen Bio Holdings Inc (TVGN) with a minimum investment of $1.
You can invest in shares of Tevogen Bio Holdings Inc (TVGN) via Vested in three simple steps:
The 52-week high price of Tevogen Bio Holdings Inc (TVGN) is $21.09. The 52-week low price of Tevogen Bio Holdings Inc (TVGN) is $0.26.
The price-to-earnings (P/E) ratio of Tevogen Bio Holdings Inc (TVGN) is 2.8571
The price-to-book (P/B) ratio of Tevogen Bio Holdings Inc (TVGN) is 0.00
The dividend yield of Tevogen Bio Holdings Inc (TVGN) is 0.00%
The market capitalization of Tevogen Bio Holdings Inc (TVGN) is $175.05M
The stock symbol (or ticker) of Tevogen Bio Holdings Inc is TVGN